Diastolic Dysfunction and Atrial Fibrillation: Recognition, Interplay, and Management
- PMID: 38780254
- DOI: 10.1097/CRD.0000000000000724
Diastolic Dysfunction and Atrial Fibrillation: Recognition, Interplay, and Management
Abstract
Diastolic dysfunction occurs when the left ventricle loses its ability to relax normally, impairing ventricular filling during diastole. This most commonly occurs as a pathological sequela of left ventricular hypertrophy and remodeling due to chronic hypertension and/or age-related sclerotic changes of the aortic valve. This can subsequently deteriorate to diastolic heart failure or heart failure with preserved ejection fraction. There is a substantive interplay between atrial fibrillation and diastolic dysfunction, as atrial fibrillation can cause, exacerbate, or be a direct result of diastolic dysfunction and vice versa. In this review, we first independently define diastolic heart failure and atrial fibrillation while discussing the diagnostic guidelines, which encompass various modalities such as medical history, electrocardiography, echocardiography, and laboratory tests. We subsequently examine their interplay and pathophysiological links drawing on recent evidence in the literature. Finally, we discuss management approaches, including pharmacological interventions targeting rate and rhythm control, diuretics, and addressing comorbidities.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosure: The authors declare no conflict of interest.
References
-
- Goldstein D, Frishman WH. Diastolic heart failure: a review of current and future treatment options. Cardiol Rev. 2021;29:82–88.
-
- Types of Heart Failure: Left-sided heart failure American Heart Association; 2024.
-
- Sherazi S, Zareba W. Diastolic heart failure: predictors of mortality. Cardiol J. 2011;18:222–232.
-
- Bozkurt B, Ahmad T, Alexander KM, et al.; Writing Committee Members. Heart failure epidemiology and outcomes statistics: a report of the heart failure society of America. J Card Fail. 2023;29:1412–1451.
-
- Rajamannan NM, Otto CM. Targeted therapy to prevent progression of calcific aortic stenosis. Circulation. 2004;110:1180–1182.
LinkOut - more resources
Full Text Sources